Follow
Viviane Dias Lima
Viviane Dias Lima
BC Centre for Excellence in HIV/AIDS & University of British Columbia
Verified email at bccfe.ca - Homepage
Title
Cited by
Cited by
Year
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
Antiretroviral Therapy Cohort Collaboration
The Lancet 372 (9635), 293-299, 2008
20042008
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
JSG Montaner, VD Lima, R Barrios, B Yip, E Wood, T Kerr, K Shannon, ...
The Lancet 376 (9740), 532-539, 2010
9562010
Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada
W Zhang, N O’Brien, JI Forrest, KA Salters, TL Patterson, JSG Montaner, ...
PloS one 7 (7), e40793, 2012
6322012
Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale‐up in the age of direct‐acting antivirals
NK Martin, P Vickerman, J Grebely, M Hellard, SJ Hutchinson, VD Lima, ...
Hepatology 58 (5), 1598-1609, 2013
5912013
Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV Treatment as Prevention” experience in aá…
JSG Montaner, VD Lima, PR Harrigan, L Lourenšo, B Yip, B Nosyk, ...
PloS one 9 (2), e87872, 2014
4432014
The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time
VD Lima, R Harrigan, DR Bangsberg, RS Hogg, R Gross, B Yip, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 50 (5), 529-536, 2009
3762009
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy
VD Lima, RS Hogg, PR Harrigan, D Moore, B Yip, E Wood, JSG Montaner
Aids 21 (6), 685-692, 2007
3472007
The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART
VD Lima, J Geller, DR Bangsberg, TL Patterson, M Daniel, T Kerr, ...
Aids 21 (9), 1175-1183, 2007
3242007
Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review andá…
RK Gupta, A Hill, AW Sawyer, A Cozzi-Lepri, V von Wyl, S Yerly, VD Lima, ...
The Lancet infectious diseases 9 (7), 409-417, 2009
3142009
Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic
VD Lima, K Johnston, RS Hogg, AR Levy, PR Harrigan, A Anema, ...
The Journal of infectious diseases 198 (1), 59-67, 2008
2762008
The cascade of HIV care in British Columbia, Canada, 1996–2011: a population-based retrospective cohort study
B Nosyk, JSG Montaner, G Colley, VD Lima, K Chan, K Heath, B Yip, ...
The Lancet infectious diseases 14 (1), 40-49, 2014
2682014
The association between food insecurity and mortality among HIV-infected individuals on HAART
SD Weiser, KA Fernandes, EK Brandson, VD Lima, A Anema, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 52 (3), 342-349, 2009
2612009
Highly active antiretroviral therapy and survival in HIV-infected injection drug users
E Wood, RS Hogg, VD Lima, T Kerr, B Yip, BDL Marshall, JSG Montaner
Jama 300 (5), 550-554, 2008
2432008
Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART
RS Hogg, DR Bangsberg, VD Lima, C Alexander, S Bonner, B Yip, ...
PLoS medicine 3 (9), e356, 2006
2402006
Differential impact of adherence on long-term treatment response among naive HIV-infected individuals
VD Lima, R Harrigan, M Murray, DM Moore, E Wood, RS Hogg, ...
Aids 22 (17), 2371-2380, 2008
2212008
N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance
SH Yap, CW Sheen, J Fahey, M Zanin, D Tyssen, VD Lima, B Wynhoven, ...
PLoS Medicine 4 (12), e335, 2007
2072007
Weight gain among treatment‐na´ve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a largeá…
K Bourgi, CA Jenkins, PF Rebeiro, BE Shepherd, F Palella, RD Moore, ...
Journal of the International AIDS Society 23 (4), e25484, 2020
1902020
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
S Patterson, A Cescon, H Samji, K Chan, W Zhang, J Raboud, ...
BMC infectious diseases 15, 1-10, 2015
1762015
Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level
VD Lima, DR Bangsberg, PR Harrigan, SG Deeks, B Yip, RS Hogg, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (4), 460-465, 2010
1762010
Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection
VS Gill, VD Lima, W Zhang, B Wynhoven, B Yip, RS Hogg, JSG Montaner, ...
Clinical infectious diseases 50 (1), 98-105, 2010
1562010
The system can't perform the operation now. Try again later.
Articles 1–20